AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36072375 — intervention group
Group type: EXPERIMENTAL
Intervention: Brisk walking (BW) exercise for 48 weeks
Number of subjects: 0
Study 34315475 — intervention group
Group type: EXPERIMENTAL
Intervention: Seasonal malaria chemoprevention (SMC) with azithromycin (AZ)
Number of subjects: 636
Study 34315475 — intervention group
Group type: COMPARATOR
Intervention: Seasonal malaria chemoprevention (SMC)
Number of subjects: 636
Study 34315475 — intervention group
Group type: COMPARATOR
Intervention: Seasonal malaria chemoprevention (SMC) and SMC + AZ
Number of subjects: 636
Study 34801002 — intervention group
Group type: EXPERIMENTAL
Intervention: body image chatbot
Number of subjects: 2800
Study 34801002 — intervention group
Group type: COMPARATOR
Intervention: assessment-only control condition
Number of subjects: 2800
Study 36327169 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose alfaxalone (LDA) 2 mg/kg
Number of subjects: 10
Study 36327169 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose alfaxalone (HDA) 5 mg/kg
Number of subjects: 10
Study 36327169 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 10
Study 35621299 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (20 mg from day 1 of the menstrual cycle till trigger day)
Number of subjects: 100
Study 35621299 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone antagonist (Cetrorelix 0.25 mg s/c from the day leading follicle reached 14 mm until trigger day)
Number of subjects: 100
Study 35621299 — intervention group
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate
Number of subjects: 100
Study 35621299 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone antagonist
Number of subjects: 100
Study 32978021 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental patellae with 1 enlarged drill hole (12 mm)
Number of subjects: 60
Study 32978021 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental patellae with 2 enlarged drill holes (12 mm)
Number of subjects: 60
Study 32978021 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental patellae with 3 enlarged drill holes (12 mm)
Number of subjects: 60
Study 32978021 — intervention group
Group type: COMPARATOR
Intervention: Control patellae
Number of subjects: 60
Study 32450979 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Inspection (VIS)
Number of subjects: 252
Study 32450979 — intervention group
Group type: COMPARATOR
Intervention: Radiographic Examination (RAD)
Number of subjects: 252
Study 36204961 — intervention group
Group type: EXPERIMENTAL
Intervention: All-ceramic onlay restoration (n=48)
Number of subjects: 95
Study 36204961 — intervention group
Group type: COMPARATOR
Intervention: Full crown restoration (Control group, n=47)
Number of subjects: 95
Study 36204961 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 95
Study 33962129 — intervention group
Group type: EXPERIMENTAL
Intervention: TEACCH training plus Discrete Trial Teaching (DTT) for six months
Number of subjects: 60
Study 33962129 — intervention group
Group type: COMPARATOR
Intervention: DTT only
Number of subjects: 60
Study 32584674 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab for FDA-approved indications
Number of subjects: 1674
Study 32584674 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab for off-label use
Number of subjects: 1674
Study 32584674 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with FDA-approved indication
Number of subjects: 1674
Study 35222900 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint injection of mecobalamin
Number of subjects: 60
Study 35222900 — intervention group
Group type: COMPARATOR
Intervention: Conventional stroke treatment and nursing
Number of subjects: 60
Study 34872568 — intervention group
Group type: EXPERIMENTAL
Intervention: Dienogest (DNG)
Number of subjects: 49
Study 34872568 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropin‐releasing hormone agonist (GnRHa)
Number of subjects: 49
Study 32732305 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive glycemic control
Number of subjects: 634
Study 32732305 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control
Number of subjects: 634
Study 32732305 — intervention group
Group type: COMPARATOR
Intervention: Standard glycemic control
Number of subjects: 634
Study 36167066 — intervention group
Group type: EXPERIMENTAL
Intervention: LSVT LOUD
Number of subjects: 34
Study 36167066 — intervention group
Group type: EXPERIMENTAL
Intervention: SpeechVive
Number of subjects: 34
Study 36167066 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 34
Study 34154628 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB) treatment group (balloon group, n = 38)
Number of subjects: 80
Study 34154628 — intervention group
Group type: COMPARATOR
Intervention: Drug-eluting stent (DES) treatment group (stent group, n = 42)
Number of subjects: 80
Study 34154628 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (DCB) treatment group (balloon group)
Number of subjects: 80
Study 34154628 — intervention group
Group type: COMPARATOR
Intervention: Drug-eluting stent (DES) treatment group (stent group)
Number of subjects: 80
Study 32233633 — intervention group
Group type: EXPERIMENTAL
Intervention: KAP-based rehabilitation education
Number of subjects: 70
Study 34551782 — intervention group
Group type: EXPERIMENTAL
Intervention: EIT‐4‐BPSD implementation strategy
Number of subjects: 93
Study 32090404 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17160
Study 36123638 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord milking (UCM)
Number of subjects: 200
Study 34029338 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-way SMS messaging
Number of subjects: 824
Study 34029338 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-way SMS messaging
Number of subjects: 824
Study 34029338 — intervention group
Group type: COMPARATOR
Intervention: Control (no SMS messaging)
Number of subjects: 824
Study 34029338 — intervention group
Group type: EXPERIMENTAL
Intervention: All arms
Number of subjects: 824
Study 32777104 — intervention group
Group type: COMPARATOR
Intervention: 400 IU
Number of subjects: 311
Study 32777104 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU
Number of subjects: 311
Study 32777104 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 IU
Number of subjects: 311
Study 35092484 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week MBSR (n=26)
Number of subjects: 51
Study 34639353 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 30
Study 34639353 — intervention group
Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 30
Study 34294068 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative Care Needs Rounds
Number of subjects: 21
Study 34889832 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-informed group (53% of participants)
Number of subjects: 127
Study 34889832 — intervention group
Group type: COMPARATOR
Intervention: Cost-blind group (47% of participants)
Number of subjects: 127
Study 34889832 — intervention group
Group type: COMPARATOR
Intervention: Cost-blind group (after receiving cost information)
Number of subjects: 127
Study 33007112 — intervention group
Group type: EXPERIMENTAL
Intervention: DensNet121 with transfer learning
Number of subjects: 112120
Study 33007112 — intervention group
Group type: EXPERIMENTAL
Intervention: CNN and radiomics-based methods
Number of subjects: 112120
Study 33007112 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer learning with good dataset selection, dropout, cycling learning rate, freezing/unfreezing layers
Number of subjects: 112120
Study 33007112 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer learning with > 35,000 images
Number of subjects: 112120
Study 33007112 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer learning using X-ray images from the same anatomical site
Number of subjects: 112120
Study 33007112 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer learning using pretrained networks from ImageNet
Number of subjects: 112120
Study 35069956 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric ropivacaine 15 mg (Group R)
Number of subjects: 50
Study 35069956 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric ropivacaine 15 mg with intrathecal fentanyl 20 μg (Group RF)
Number of subjects: 50
Study 35069956 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Group R and Group RF)
Number of subjects: 50
Study 32838678 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted School Mental Health Program (SMHP)
Number of subjects: 960
Study 35861630 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 308
Study 35861630 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin and Placebo
Number of subjects: 308
Study 34284154 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifamily psychoeducational program (EG)
Number of subjects: 296
Study 34284154 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 296
Study 35779894 — intervention group
Group type: EXPERIMENTAL
Intervention: Teherán‐Morales's color grading scale
Number of subjects: 150
Study 35779894 — intervention group
Group type: COMPARATOR
Intervention: Subjective assessment by experts
Number of subjects: 150
Study 35928886 — intervention group
Group type: EXPERIMENTAL
Intervention: Late afternoon endurance exercise
Number of subjects: 12
Study 34865095 — intervention group
Group type: EXPERIMENTAL
Intervention: Local oxygen-ozone therapy plus medical treatment (n=13)
Number of subjects: 25
Study 34865095 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment only (Control group, n=12)
Number of subjects: 25
Study 32705692 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose oral rifampin (RIF)
Number of subjects: 0
Study 32705692 — intervention group
Group type: COMPARATOR
Intervention: Renal impairment (RI)
Number of subjects: 0
Study 33121523 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular or surgical management
Number of subjects: 1212
Study 33121523 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative treatments
Number of subjects: 1212
Study 33121523 — intervention group
Group type: COMPARATOR
Intervention: Standard treatments
Number of subjects: 1212
Study 34893397 — intervention group
Group type: EXPERIMENTAL
Intervention: Backboard
Number of subjects: 120
Study 34893397 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study 32054287 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools (Sun Safe Schools intervention)
Number of subjects: 118
Study 32054287 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 118
Study 32054287 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention schools
Number of subjects: 118
Study 32504611 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweeted articles
Number of subjects: 112
Study 32504611 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization to tweeting
Number of subjects: 112
Study 33940662 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensibilize KF with potassium nitrate and 0.2% sodium fluoride (PN)
Number of subjects: 30
Study 33940662 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxa-Gel with potassium oxalate (PO)
Number of subjects: 30
Study 33940662 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30
Study 33778994 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support groups (engaging in income generation, table banking, addressing food security, financial and moral support)
Number of subjects: 20
Study 33778994 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support groups (monthly for the first two months, then every three months for the remainder of the year)
Number of subjects: 20
Study 36269852 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin, 400 μg/kg, daily for 3 days (n=817)
Number of subjects: 1591
Study 36269852 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=774)
Number of subjects: 1591
Study 34315237 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted insomnia
Number of subjects: 0
Study 33897216 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational plan based on Roy adaptation model, delivered through face-to-face and group training program in 6 sessions over one month, followed by a 4-week follow-up period.
Number of subjects: 60
Study 33897216 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 60
Study 35668348 — intervention group
Group type: EXPERIMENTAL
Intervention: CACB+IPACK
Number of subjects: 0
Study 35668348 — intervention group
Group type: COMPARATOR
Intervention: CACB+SHAM
Number of subjects: 0
Study 32746899 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonic conventional stimulation (TCS)
Number of subjects: 28
Study 32746899 — intervention group
Group type: EXPERIMENTAL
Intervention: Burst stimulation (BURST)
Number of subjects: 28
Study 32746899 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency stimulation (HF)
Number of subjects: 28
Study 33301188 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculation with Thiobacillus sp.
Number of subjects: 3
Study 33301188 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculation with Funneliformis mosseae
Number of subjects: 3
Study 33301188 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculation with Funneliformis mosseae + Thiobacillus sp.
Number of subjects: 3
Study 33301188 — intervention group
Group type: COMPARATOR
Intervention: No-inoculation
Number of subjects: 3
Study 33301188 — intervention group
Group type: COMPARATOR
Intervention: Control (0.91 dS/m)
Number of subjects: 3
Study 34057752 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative 3D-computed tomography (CT) and gait analysis
Number of subjects: 60
Study 34057752 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinematic pelvic changes during gait
Number of subjects: 60
Study 34057752 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinematic pelvic changes
Number of subjects: 60
Study 34057752 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative cup position
Number of subjects: 60
Study 34057752 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors correlating with pelvic mobility
Number of subjects: 60
Study 32628676 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteome‐by‐phenome Mendelian Randomization (MR) using 64 replicated locally‐acting variants as instrumental variables
Number of subjects: 509
Study 32628676 — intervention group
Group type: EXPERIMENTAL
Intervention: Proteome‐by‐phenome MR
Number of subjects: 509
Study 32628676 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal role of tyrosine‐protein phosphatase non‐receptor type substrate 1 (SHPS1; SIRPA)
Number of subjects: 509
Study 32628676 — intervention group
Group type: EXPERIMENTAL
Intervention: Intestinal fatty acid binding protein (FABP2) abundance
Number of subjects: 509
Study 32628676 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal role of four proteins (FGF5, IL6R, LPL, LTA)
Number of subjects: 509
Study 35157370 — intervention group
Group type: EXPERIMENTAL
Intervention: GDC-0214 (15 mg twice daily for 14 days)
Number of subjects: 66
Study 35157370 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-radiolabeled GDC-0214 (1 mg)
Number of subjects: 66
Study 35157370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 35644155 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous risankizumab 360 mg
Number of subjects: 542
Study 35644155 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous risankizumab 180 mg
Number of subjects: 542
Study 35644155 — intervention group
Group type: COMPARATOR
Intervention: Withdrawal (subcutaneous placebo)
Number of subjects: 542
Study 32420624 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial experimental treatment
Number of subjects: 0
Study 32420624 — intervention group
Group type: COMPARATOR
Intervention: Initial control treatment
Number of subjects: 0
Study 33820412 — intervention group
Group type: EXPERIMENTAL
Intervention: DistrACTION® Cards (MMJ Labs)
Number of subjects: 104
Study 33820412 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 104
Study 34384459 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I), delivered in-person or via telehealth, five weekly sessions.
Number of subjects: 62
Study 34384459 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 62
Study 34384459 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 62
Study 33560210 — intervention group
Group type: EXPERIMENTAL
Intervention: Level 3 portable sleep study device
Number of subjects: 107
Study 33560210 — intervention group
Group type: COMPARATOR
Intervention: In-laboratory polysomnography
Number of subjects: 107
Study 36073088 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga and aerobic exercise
Number of subjects: 12
Study 33173114 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow induction group
Number of subjects: 18
Study 33173114 — intervention group
Group type: COMPARATOR
Intervention: Fast induction group
Number of subjects: 18
Study 33836459 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 130
Study 33836459 — intervention group
Group type: COMPARATOR
Intervention: Moderate Continuous Exercise (MCT)
Number of subjects: 130
Study 32164442 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Milieu Teaching with Phonological Emphasis (EMT + PE)
Number of subjects: 30
Study 32164442 — intervention group
Group type: COMPARATOR
Intervention: Business as usual comparison condition
Number of subjects: 30
Study 34467531 — intervention group
Group type: EXPERIMENTAL
Intervention: Karman aspiration cannula
Number of subjects: 40
Study 34467531 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 40
Study 34153968 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose alteplase (0.6 mg/kg)
Number of subjects: 4551
Study 34153968 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose alteplase (0.9 mg/kg)
Number of subjects: 4551
Study 34153968 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (target SBP 130-140 mm Hg)
Number of subjects: 4551
Study 34153968 — intervention group
Group type: COMPARATOR
Intervention: Guideline-recommended blood pressure management (<180 mm Hg)
Number of subjects: 4551
Study 34044689 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential settings (4.5‐µm spot and track spacing in cap interface and 4.2 µm in lenticule interface)
Number of subjects: 50
Study 34044689 — intervention group
Group type: COMPARATOR
Intervention: Standard settings (4.5‐µm spot and track spacing in cap and lenticule interface)
Number of subjects: 50
Study 34044689 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential settings
Number of subjects: 50
Study 34044689 — intervention group
Group type: COMPARATOR
Intervention: Standard settings
Number of subjects: 50
Study 34044689 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 32122834 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 2% diluted with dextrose 5%
Number of subjects: 60
Study 32122834 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 2% diluted with normal saline
Number of subjects: 60
Study 35656654 — intervention group
Group type: EXPERIMENTAL
Intervention: LLLT of 660 nm
Number of subjects: 80
Study 35656654 — intervention group
Group type: EXPERIMENTAL
Intervention: LLLT of 810 nm
Number of subjects: 80
Study 35656654 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of wavelengths 660 and 810 nm
Number of subjects: 80
Study 35656654 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 80
Study 33639904 — intervention group
Group type: EXPERIMENTAL
Intervention: ART (Antiretroviral Therapy)
Number of subjects: 512
Study 33639904 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with higher rates of stops/starts
Number of subjects: 512
Study 33639904 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with lower rates of stops/starts
Number of subjects: 512
Study 33639904 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with longer durations of sustained ART
Number of subjects: 512
Study 33639904 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with shorter durations of sustained ART
Number of subjects: 512
Study 34979252 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g of TXA intravenously q12 hours from postadmission day 1 to the day before surgery and 1.5 g of TXA q12 hours from postoperative day 1 to postoperative day 3
Number of subjects: 96
Study 34979252 — intervention group
Group type: COMPARATOR
Intervention: 100 mL of normal saline intravenously q12 hours from postadmission day 1 to the day before surgery and 1.5 g of TXA q12 hours from postoperative day 1 to postoperative day 3
Number of subjects: 96
Study 33484658 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based humanistic counselling (SBHC) plus pastoral care as usual (PCAU)
Number of subjects: 329
Study 33484658 — intervention group
Group type: COMPARATOR
Intervention: Pastoral care as usual (PCAU)
Number of subjects: 329
Study 32947619 — intervention group
Group type: EXPERIMENTAL
Intervention: Various therapies for multiple sclerosis (10 therapies analyzed for relapses)
Number of subjects: 11180
Study 32947619 — intervention group
Group type: EXPERIMENTAL
Intervention: Various therapies for multiple sclerosis (7 therapies analyzed for disability progression)
Number of subjects: 11180
Study 32947619 — intervention group
Group type: EXPERIMENTAL
Intervention: All therapies except intramuscular interferon beta-1a
Number of subjects: 11180
Study 35902868 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with D1cc ≥ 55.8 Gy for brainstem
Number of subjects: 74
Study 35902868 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with D1cc ≥ 72.1 Gy for brain
Number of subjects: 74
Study 35902868 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with Dmax ≥ 36.6 Gy for eyeball
Number of subjects: 74
Study 35902868 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with Dmean ≥ 44 Gy for ipsilateral inner ear
Number of subjects: 74